Filana Therapeutics, Inc. (FLNA)
NASDAQ: FLNA · Real-Time Price · USD
0.8860
-0.0387 (-4.19%)
At close: Sep 30, 2026, 4:00 PM EDT
0.9500
+0.0640 (7.22%)
After-hours: Sep 30, 2026, 7:59 PM EDT
Filana Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Cost of Revenue | 15.66 | 17.47 | 26.59 | 43.27 | 56.99 | 67.07 | 69.64 | 67.84 | 120.07 | 83.54 | 89.42 | 88.34 | 36.96 | 75.25 | 68.03 | 60.72 | 50.24 | 37.19 | 24.81 | 15.99 |
Gross Profit | -15.66 | -17.47 | -26.59 | -43.27 | -56.99 | -67.07 | -69.64 | -67.84 | -120.07 | -83.54 | -89.42 | -88.34 | -36.96 | -75.25 | -68.03 | -60.72 | -50.24 | -37.19 | -24.81 | -15.99 |
Selling, General & Admin | -1.98 | 32.2 | 33.5 | 65.06 | 71.2 | 82.93 | 81.71 | 76.71 | 67.04 | 18.84 | 16.63 | 15.86 | 14.3 | 13.47 | 11.99 | 12.81 | 11.7 | 9.97 | 8.06 | 5.06 |
Research & Development | - | - | - | - | - | - | - | - | -46.31 | - | - | - | 46.31 | - | - | - | - | - | - | - |
Operating Expenses | -1.98 | 32.2 | 33.5 | 65.06 | 71.2 | 82.93 | 81.71 | 76.71 | 20.73 | 18.84 | 16.63 | 15.86 | 60.61 | 13.47 | 11.99 | 12.81 | 11.7 | 9.97 | 8.06 | 5.06 |
Operating Income | -13.67 | -49.67 | -60.09 | -108.33 | -128.19 | -150 | -151.35 | -144.55 | -140.8 | -102.38 | -106.06 | -104.21 | -97.57 | -88.71 | -80.02 | -73.53 | -61.94 | -47.16 | -32.87 | -21.05 |
Interest & Investment Income | 3.68 | 4.14 | 4.62 | 5.45 | 6.9 | 8 | 8.51 | 8.29 | 7.68 | 7.56 | 7.83 | 7.81 | 6.68 | 4.8 | 2.78 | 1.24 | 0.37 | 0.07 | 0.05 | 0.04 |
Other Non Operating Income (Expenses) | 0.02 | -0.07 | -0.2 | -0.15 | 0.02 | 65.31 | 108.59 | 108.8 | 108.96 | 43.92 | 0.91 | 0.87 | 0.85 | 0.92 | 1 | 1.01 | 0.97 | 0.7 | 0.43 | 0.18 |
EBT Excluding Unusual Items | -9.98 | -45.6 | -55.67 | -103.03 | -121.27 | -76.69 | -34.24 | -27.46 | -24.17 | -50.9 | -97.32 | -95.53 | -90.04 | -82.99 | -76.25 | -71.28 | -60.59 | -46.39 | -32.39 | -20.83 |
Legal Settlements | -32.3 | -32.3 | -35.3 | -3 | -3 | -3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Pretax Income | -42.28 | -77.9 | -90.97 | -106.03 | -123.17 | -72.79 | -24.34 | -17.66 | -15.37 | -47.9 | -97.22 | -95.43 | -90.04 | -82.99 | -76.25 | -71.28 | -60.59 | -46.39 | -32.39 | -20.83 |
Net Income | -42.28 | -77.9 | -90.97 | -106.03 | -123.17 | -72.79 | -24.34 | -17.66 | -15.37 | -47.9 | -97.22 | -95.43 | -90.04 | -82.99 | -76.25 | -71.28 | -60.59 | -46.39 | -32.39 | -20.83 |
Net Income to Common | -42.28 | -77.9 | -90.97 | -106.03 | -123.17 | -72.79 | -24.34 | -17.66 | -15.37 | -47.9 | -97.22 | -95.43 | -90.04 | -82.99 | -76.25 | -71.28 | -60.59 | -46.39 | -32.39 | -20.83 |
Net Income Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding (Basic) | 48 | 48 | 48 | 48 | 48 | 48 | 46 | 45 | 43 | 42 | 42 | 42 | 41 | 41 | 40 | 40 | 40 | 40 | 39 | 37 |
Shares Outstanding (Diluted) | 48 | 48 | 48 | 48 | 48 | 48 | 47 | 45 | 43 | 42 | 42 | 42 | 41 | 41 | 40 | 40 | 40 | 40 | 39 | 37 |
Shares Change (YoY) | 0.24% | 1.39% | 3.63% | 7.61% | 11.15% | 12.77% | 11.14% | 7.86% | 5.50% | 3.94% | 4.30% | 3.95% | 2.78% | 1.70% | 2.02% | 8.22% | 20.37% | 35.87% | 50.95% | 60.00% |
EPS (Basic) | -0.88 | -1.61 | -1.88 | -2.20 | -2.56 | -1.53 | -0.53 | -0.39 | -0.35 | -1.13 | -2.32 | -2.30 | -2.19 | -2.04 | -1.90 | -1.78 | -1.52 | -1.16 | -0.82 | -0.56 |
EPS (Diluted) | -0.88 | -1.61 | -1.88 | -2.20 | -2.56 | -1.53 | -1.46 | -1.37 | -1.37 | -2.17 | -2.32 | -2.30 | -2.19 | -2.04 | -1.90 | -1.78 | -1.52 | -1.16 | -0.82 | -0.56 |
EPS Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Additional Metrics
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Free Cash Flow | -29.3 | -30.38 | -32.83 | -83.91 | -95.92 | -109.24 | -117.03 | -78.07 | -86.31 | -87.95 | -82.44 | -81.07 | -77.22 | -69.88 | -80.23 | -67.33 | -81.43 | -74.06 | -52.41 | -45.5 |
Free Cash Flow Per Share | -0.61 | -0.63 | -0.68 | -1.74 | -1.99 | -2.29 | -2.51 | -1.74 | -1.99 | -2.08 | -1.97 | -1.95 | -1.88 | -1.72 | -2.00 | -1.68 | -2.04 | -1.85 | -1.33 | -1.23 |
EBITDA | -12.69 | -48.71 | -59.15 | -107.5 | -127.23 | -148.96 | -150.21 | -143.32 | -139.44 | -100.93 | -104.53 | -102.64 | -96.1 | -87.33 | -78.72 | -72.3 | -60.8 | -46.31 | -32.33 | -20.83 |
D&A For EBITDA | 0.99 | 0.96 | 0.94 | 0.83 | 0.96 | 1.04 | 1.13 | 1.23 | 1.36 | 1.45 | 1.53 | 1.56 | 1.47 | 1.38 | 1.3 | 1.23 | 1.14 | 0.85 | 0.53 | 0.22 |
EBIT | -13.67 | -49.67 | -60.09 | -108.33 | -128.19 | -150 | -151.35 | -144.55 | -140.8 | -102.38 | -106.06 | -104.21 | -97.57 | -88.71 | -80.02 | -73.53 | -61.94 | -47.16 | -32.87 | -21.05 |